Aidoc has raised $150M to accelerate development of its CARE foundation model for clinical AI in radiology and beyond.
Key Details
- 1Aidoc secured $150M in funding, bringing total raised to $370M since 2016.
- 2Investors include major U.S. hospital systems and venture capital firms; $40M is a revolving credit line.
- 3Funds will accelerate CARE, a clinical-grade foundation AI model adaptable across diseases.
- 4CARE aims to cover 90% of clinically relevant diseases within three years, including cancer and cardiovascular conditions.
- 5Aidoc supports decision-making for over 45 million patients annually across 150+ health systems.
- 6Company has over 20 FDA clearances and plans significant investment via partnerships with Nvidia and AWS.
Why It Matters
Aidoc's funding enables rapid development and scaling of foundational imaging AI, with potential to cover most clinically relevant diseases and support broader, system-wide AI adoption. Such progress could shift the landscape for radiologists and health systems, impacting workflow, diagnostics, and patient outcomes.
Source
Radiology Business
Related News
•Radiology Business
Aidoc Raises $150M to Expand Imaging AI Portfolio and Global Reach
Aidoc secures $150M in Series E funding led by Goldman Sachs to accelerate expansion of its clinical AI platform.
•AuntMinnie
AI in Radiology: Augmentation, Not Replacement – Risks and Realities Reviewed
AI is reshaping radiology workflows but is not ready to replace radiologists, as judgment, accountability, and clinical complexity remain unmet by current technology.
•AuntMinnie
AI-Driven Mammogram Analysis Boosts Cardiovascular Risk Prediction in Women
AI quantification of breast arterial calcifications (BACs) on mammograms enhances prediction of cardiovascular events beyond traditional risk models.